1 / 8

Angioedema

Angioedema. Overview. Self-Limited, subcutaneous edema resulting from increased vascular permeability Dilation of venules and capillaries Different from urticaria Limited to the superficial dermis Generally resolves over 24-48 hours Mast Cell / Kinin related etiologies

zoie
Télécharger la présentation

Angioedema

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Angioedema

  2. Overview • Self-Limited, subcutaneous edema resulting from increased vascular permeability • Dilation of venules and capillaries • Different from urticaria • Limited to the superficial dermis • Generally resolves over 24-48 hours • Mast Cell / Kinin related etiologies • Involvement of the lips, pharynx and bowel common (potentially life-threatening) • Treated with CCS and H1/H2 blockers • FFP has been used in C1-Inh deficiency

  3. Etiology • Immunologic / IgE mediated • elicited by foods, additives, drugs, transfusions, insect bites and infection • Release of vasoactive mediators from mast cells • Urticaria and pruritis • Hereditary and Acquired (non-mast cell) • Bradykinin and complement-mediated increases in vasc perm. • ACE-I or NSAID

  4. Ace-Inhibitors • ACE (Kininase II) degrades bradykinin • Vasodilator • ACE-I results in inc levels bradykinin • Vasc B-2 rec’s for vasodilation, inc perm, inc NO • Not related to ACE-I induced cough • Pts with genetic deficiencies in bradykinin degradation could be at higher risk • 0.1-0.7% of patients tx with ACE-I • Intestinal edema may develop • Sudden onset abdom pain, vomiting and diarrhea

  5. ACE-I • 50% of cases occur within 1 week of tx • Others may occur years later • Class specific • ARB’s - have been linked to episodes of angioedema • 2 of 26 pts with ACE-I induced angioedema persisted with an ARB and resolved with its withdrawal • Switch with caution

  6. Hereditary/Acquired • Kinin-mediated angioedema that may be unmasked with use of ACE-I • C1-Inh deficiency (level or fx) - Inc BKinin • Normally fx to degrade C1 and prevent excessive complement activation • Dec levels of C1, C2, C4 • Acquired- malignancy or auto-antibodies (older onset)

  7. Summary • Angioedema is potentially life-threatening • Associated pruritis and hives points to anaphylaxis • Absence of pruritis and hives think ACE-I and/or C1-Inh deficiency • PMHx, FHx, Malignancy • Use caution when switching from an ACE-I to an ARB

More Related